Literature DB >> 22811067

Dimerization in the Grb7 protein.

Tabitha A Peterson1, Renee L Benallie, Andrew M Bradford, Sally C Pias, Jaron Yazzie, Siamee N Lor, Zachary M Haulsee, Chad K Park, Dennis L Johnson, Larry R Rohrschneider, Anne Spuches, Barbara A Lyons.   

Abstract

In previous studies, we showed that the tyrosine phosphorylation state of growth factor receptor-bound protein 7 (Grb7) affects its ability to bind to the transcription regulator FHL2 and the cortactin-interacting protein, human HS-1-associated protein-1. Here, we present results describing the importance of dimerization in the Grb7-Src homology 2 (SH2) domain in terms of its structural integrity and the ability to bind phosphorylated tyrosine peptide ligands. A tyrosine phosphorylation-mimic mutant (Y80E-Grb7-SH2) is largely dimerization deficient and binds a tyrosine-phosphorylated peptide representative of the receptor tyrosine kinase (RTK) erbB2 with differing thermodynamic characteristics than the wild-type SH2 domain. Another dimerization-deficient mutant (F99R-Grb7-SH2) binds the phosphorylated erbB2 peptide with similarly changed thermodynamic characteristics. Both Y80E-Grb7-SH2 and F99R-Grb7-SH2 are structured by circular dichroism measurements but show reduced thermal stability relative to the wild type-Grb7-SH2 domain as measured by circular dichroism and nuclear magnetic resonance. It is well known that the dimerization state of RTKs (as binding partners to adaptor proteins such as Grb7) plays an important role in their regulation. Here, we propose the phosphorylation state of Grb7-SH2 domain tyrosine residues could control Grb7 dimerization, and dimerization may be an important regulatory step in Grb7 binding to RTKs such as erbB2. In this manner, additional dimerization-dependent regulation could occur downstream of the membrane-bound kinase in RTK-mediated signaling pathways.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22811067      PMCID: PMC3758474          DOI: 10.1002/jmr.2205

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  36 in total

1.  Dimer formation through domain swapping in the crystal structure of the Grb2-SH2-Ac-pYVNV complex.

Authors:  N Schiering; E Casale; P Caccia; P Giordano; C Battistini
Journal:  Biochemistry       Date:  2000-11-07       Impact factor: 3.162

2.  Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.

Authors:  Pierre Nioche; Wang-Qing Liu; Isabelle Broutin; Franck Charbonnier; Marie-Thérèse Latreille; Michel Vidal; Bernard Roques; Christiane Garbay; Arnaud Ducruix
Journal:  J Mol Biol       Date:  2002-02-01       Impact factor: 5.469

3.  Inhibition of hGrb10 binding to the insulin receptor by functional domain-mediated oligomerization.

Authors:  L Q Dong; S Porter; D Hu; F Liu
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

4.  Rapid measurement of binding constants and heats of binding using a new titration calorimeter.

Authors:  T Wiseman; S Williston; J F Brandts; L N Lin
Journal:  Anal Biochem       Date:  1989-05-15       Impact factor: 3.365

5.  Isothermal titration calorimetry measurements of Ni(II) and Cu(II) binding to His, GlyGlyHis, HisGlyHis, and bovine serum albumin: a critical evaluation.

Authors:  Y Zhang; S Akilesh; D E Wilcox
Journal:  Inorg Chem       Date:  2000-07-10       Impact factor: 5.165

6.  Grb7 binds to Hax-1 and undergoes an intramolecular domain association that offers a model for Grb7 regulation.

Authors:  Sharareh Siamakpour-Reihani; Tabitha A Peterson; Andrew M Bradford; Haroula J Argiros; Laura Lowell Haas; Siamee N Lor; Zachary M Haulsee; Anne M Spuches; Dennis L Johnson; Larry R Rohrschneider; Charles Brad Shuster; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2011 Mar-Apr       Impact factor: 2.137

7.  Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.

Authors:  Monika Ivancic; Roger J Daly; Barbara A Lyons
Journal:  J Biomol NMR       Date:  2003-11       Impact factor: 2.835

8.  A novel variant of human Grb7 is associated with invasive esophageal carcinoma.

Authors:  S Tanaka; M Mori; T Akiyoshi; Y Tanaka; K Mafune; J R Wands; K Sugimachi
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

9.  Cloning and characterization of GRB14, a novel member of the GRB7 gene family.

Authors:  R J Daly; G M Sanderson; P W Janes; R L Sutherland
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

10.  Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group.

Authors:  R Seshadri; F A Firgaira; D J Horsfall; K McCaul; V Setlur; P Kitchen
Journal:  J Clin Oncol       Date:  1993-10       Impact factor: 44.544

View more
  4 in total

1.  Binding and function of phosphotyrosines of the Ephrin A2 (EphA2) receptor using synthetic sterile α motif (SAM) domains.

Authors:  Susmita Borthakur; HyeongJu Lee; SoonJeung Kim; Bing-Cheng Wang; Matthias Buck
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

2.  Grb7 and Filamin-a associate and are colocalized to cell membrane ruffles upon EGF stimulation.

Authors:  Prakash Paudyal; Sanjay Shrestha; Thushara Madanayake; Charles B Shuster; Larry R Rohrschneider; Aaron Rowland; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2013-11       Impact factor: 2.137

3.  Grb7-derived calmodulin-binding peptides inhibit proliferation, migration and invasiveness of tumor cells while they enhance attachment to the substrate.

Authors:  Juan Alcalde; María González-Muñoz; Antonio Villalobo
Journal:  Heliyon       Date:  2020-05-07

Review 4.  Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target.

Authors:  Pei-Yu Chu; Yu-Ling Tai; Tang-Long Shen
Journal:  Cells       Date:  2019-05-10       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.